Sullivan Timothy Eugene

CIK 00017070002 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001707000

Recent Transactions

50 trades

Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-22$21.77/sh−10,287→ 93,901 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-20$19.79/sh−2,892→ 104,188 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-10-21−10,000→ 232,903 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-10-21$28.03/sh−10,000→ 110,936 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-10-21$10.03/sh+10,000→ 120,936 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-09-08$27.86/sh−32,729→ 110,936 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-09-08−15,000→ 242,903 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-09-08$10.03/sh+15,000→ 143,665 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-09-08$27.83/sh−10,000→ 60,396 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-06-09$19.39/sh+82,500→ 82,500 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-29$29.52/sh−546→ 128,665 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-22$30.43/sh−3,088→ 129,211 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-21+45,929→ 132,299 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-17$29.96/sh−1,730→ 86,370 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-13$28.70/sh−2,170→ 88,100 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-12-31$14.95/sh+1,042→ 80,216 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-12-31−1,042→ 23,958 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-12-31−10,054→ 84,946 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-12-31$13.85/sh+10,054→ 90,270 total
Gift
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-04-18+14,164→ 70,396 total
Gift
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-04-18−14,164→ 79,174 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-04-01−4,000→ 257,903 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-04-01$58.66/sh−4,000→ 93,338 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-04-01$10.03/sh+4,000→ 97,338 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-03-01$62.86/sh−4,000→ 95,338 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-03-01$10.03/sh+6,000→ 99,338 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-03-01$63.95/sh−2,000→ 93,338 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-03-01−6,000→ 261,903 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-02-12$67.77/sh−1,431→ 93,338 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-29$64.14/sh−906→ 94,769 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-22$65.00/sh−3,551→ 95,675 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-16$66.30/sh+34,533→ 34,533 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16+23,748→ 101,461 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16$66.81/sh−2,235→ 99,226 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-11-30$54.79/sh−300→ 77,713 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-11-30$54.73/sh−13,858→ 78,013 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-11-30$10.03/sh+14,158→ 91,871 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-11-30−14,158→ 267,903 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-03$90.42/sh−3,287→ 78,013 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-03$10.03/sh+6,779→ 84,492 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-03$91.10/sh−300→ 77,713 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-07-03−6,779→ 282,061 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-07-03$89.41/sh−3,192→ 81,300 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-05$88.36/sh−7,064→ 108,219 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-05$87.79/sh−30,609→ 115,283 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-06-05−69,779→ 288,840 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-05$90.60/sh−1,600→ 145,892 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-05$10.03/sh+69,779→ 147,492 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-06-05$89.83/sh−30,506→ 77,713 total
Gift
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-05-03−20,000→ 77,713 total

Companies

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov